MicroQuin

San Francisco, United States Founded: 2016 • Age: 10 yrs
Developer of therapies for treating multiple diseases

About MicroQuin

MicroQuin is a company based in San Francisco (United States) founded in 2016 by Scott Robinson.. MicroQuin offers products and services including SMQ-2174. MicroQuin operates in a competitive market with competitors including Jazz Pharmaceuticals, Moderna, Adaptive Biotechnologies, C4 Therapeutics and UCB, among others.

  • Headquarter San Francisco, United States
  • Founders Scott Robinson
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $999.3 K (USD), Grant

    Sep 30, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MicroQuin

MicroQuin offers a comprehensive portfolio of products and services, including SMQ-2174. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Small molecule that induces rapid cancer cell death in solid tumors.

People of MicroQuin
Headcount 1-10
Employee Profiles 2
Employee Profiles
People
Scott Robinson
Founder & CEO
People
Scott Robinson, PhD, CQF
President and CSO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of MicroQuin

  • Total Funding
  • Total Rounds 4
  • Last Round Grant — $999,300
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2023 Amount Grant - MicroQuin Valuation

investors

Jun, 2023 Amount Grant - MicroQuin Valuation

investors

Jul, 2022 Amount Grant - MicroQuin Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MicroQuin

MicroQuin has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Military Health and MassChallenge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
Administers health care and support for military personnel and operations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MicroQuin

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MicroQuin

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Microquin Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MicroQuin

MicroQuin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Moderna, Adaptive Biotechnologies, C4 Therapeutics and UCB, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Clinical diagnostics and drug discovery for immune diseases are provided.
domain founded_year HQ Location
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
domain founded_year HQ Location
Therapies for immunological and neurological disorders are developed.
domain founded_year HQ Location
Small molecule therapeutics for cancer treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Microquin

Frequently Asked Questions about MicroQuin

When was MicroQuin founded?

MicroQuin was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is MicroQuin located?

MicroQuin is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

What does MicroQuin do?

MicroQuin was founded in 2016 in San Francisco, United States, within the biotechnology sector. Therapies for treating multiple diseases are developed, with a focus on modulating TMBIM6, an intracellular transmembrane protein. A drug pipeline targeting oncology, infectious diseases, and Parkinsons disease has been established. Operations center on creating targeted therapeutics to address these conditions.

Who are the top competitors of MicroQuin?

MicroQuin's top competitors include Moderna, Jazz Pharmaceuticals and C4 Therapeutics.

What products or services does MicroQuin offer?

MicroQuin offers SMQ-2174.

Who are MicroQuin's investors?

MicroQuin has 2 investors. Key investors include Military Health, and MassChallenge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available